2m 2m 2m 2m 2m 2m 2m
Corcept Therapeu (CORT)
NASDAQ
$108.90+$1.39 (+1.30%)
Price as of Oct 22, 2026 7:50 PM EDT- $12.6BMarket Cap
- 57.88%1-Year Change
- BiotechnologyIndustry
Corcept Therapeu (CORT)
$108.90+$1.39 (+1.30%)
CORT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $107.50 | ||
Change | -$0.17 (-0.15%) | ||
Open | $115.16 | ||
High | $115.73 | ||
Low | $107.33 | ||
Previous Close | $116.28 | ||
Volume | 809,884 | ||
30-Day Average Volume | 779,113 | ||
1-Week Change | 0.04% | ||
1-Month Change | 2.22% | ||
1-Year Change | 57.88% | ||
3-Year Change | 316.48% | ||
5-Year Change | 518.18% | ||
Fundamentals | |||
Shares Outstanding | 108.1M | ||
Total Assets | $888.7M | ||
Market Cap | $12.6B | ||
Enterprise Value | $12.5B | ||
Period: QTR TTM FY | |||
Revenue | $256.1M | ||
Net Income | $43.0M | ||
Free Cash Flow | $31.0M | ||
EBIT | $45.9M | ||
EBITDA | $46.8M | ||
Net Working Capital | $285.9M | ||
EPS | $0.36 | ||
Enterprise Value/EBITDA | 266 | ||
Enterprise Value/Revenue | 49 | ||
P/B | 18 | ||
P/E | 323 | ||
PEG | 1 | ||
Price/Free Cash Flow | 405 | ||
Price/Operating Cash Flow | 375 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue